*What Retatrutide is*
Retatrutide is an experimental weight-loss drug in late-stage trials. It works as a triple agonist: it targets GLP-1, GIP, and glucagon receptors to reduce appetite, slow gastric emptying, and increase energy use. Early trial data showed significant weight loss in people with obesity, which is why it’s getting attention alongside semaglutide and tirzepatide.
*Key points for your beauty/weight loss clients*
- It’s injectable, usually weekly, like other GLP-1 meds.